Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.

Chueh-Yi HuangYuh-Cheng YangTze-Chien ChenJen-Ruei ChenYu-Jen ChenMeng-Hao WuYa-Ting JanChih-Long ChangJie Lee

Published in: Journal of cachexia, sarcopenia and muscle (2020)

Skeletal muscle index decreased significantly during treatment and was independently associated with poor overall survival in patients with stage III EOC treated with PDS and adjuvant platinum-based chemotherapy. The modified Glasgow prognostic score might be a predictor of SMI loss during treatment.

Keyphrases

skeletal muscle
locally advanced
minimally invasive
neoadjuvant chemotherapy
insulin resistance
early stage
free survival
coronary artery bypass
adipose tissue
squamous cell carcinoma
coronary artery disease
surgical site infection
chemotherapy induced
newly diagnosed
percutaneous coronary intervention